Meet Paul F. Rashid, MD, our new Advisory Board Member and investor. We are so fortunate to have him aboard! iAssay has an EarlyBird investment special for a short time. Visit the site for more details: www.WeFunder.com/iAssay
For Release March 8, 2021 iAssay and DDTD Tag Team Against COVID-19 San Diego— March 8, 2021 — iAssay, Inc., and DDTD (Drugs & Diagnostics for Tropical Diseases), a 501(c)(3) nonprofit, have signed a Memorandum of Understanding (MOU). DDTD is a mission-driven organization to develop accurate, affordable, mass-market treatments and diagnostics for low-resourced and under-served […]
We are pleased to share a recording of iAssay’s recent webinar. In this video iAssay’s Founder and CEO, Lonnie Adelman presents an overview of the medical testing industry and explains the trend to point of care testing. He then discusses the company’s breakthrough point of care product, SimpleTest™, and how this device is positioned to […]
Hello, I am reaching out to our investors and future investors to invite you to a Zoom Webinar to share more details about our new and exciting SimpleTest™ product ( www.WeFunder.com/iAssay ) that is completely revolutionizing the medical testing industry. Here are the details for the Webinar: When: Mar 2, 2021 12:00 PM Eastern Time […]
Dear investors, I am pleased to share some exciting news with you…We are no longer pre-revenue! GattaCo, makers of next generation medical diagnostics and simplified sample collection and processing, has signed a Memorandum of Understanding (MOU) with iAssay enabling engineers and scientists to work together to integrate and optimize their products to provide accurate, enhanced […]
During the week of January 11, 2021, JP Morgan conducted their annual healthcare conference. Having attended for several years we wanted to provide a few relevant highlights for our investors. As a consequence of the COVID-19 pandemic there has been an increased acceptance in the use of point of care testing to determine who has […]
iAssay is honored to have been included in this All Things Technology issue, Industry News Spotlight. See it here: https://lnkd.in/gXtBYU3
Murrieta / San Diego— 11/10/2020 — Today GattaCo and iAssay announced that they have signed a Memorandum of Understanding (MOU), enabling engineers and scientists to work together to integrate and optimize their products in an effort to provide enhanced rapid serology testing, including COVID-19 antibody testing and electronic test result transmission to federal and state […]
We are excited to share the stage with so many top talents in the innovation space. The patented iAssay® System is a handheld medical test reader. It is agnostic to test type, and features an expandable test menu for testing patients at point of care using a fingerstick blood sample or urine sample. Flexibility by […]
iAssay automatically sends COVID-19 test results to the Cloud! This has always been a part of the plan because of its anticipated importance. Now that HHS has mandated that COVID-19 test results be sent to them periodically, iAssay will have you covered! Comply with us! Courtesy of Patricia Jones, PhD and The AACC On September […]